Andreas Fløe

761 total citations · 1 hit paper
38 papers, 325 citations indexed

About

Andreas Fløe is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Andreas Fløe has authored 38 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Andreas Fløe's work include Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (16 papers) and Pneumonia and Respiratory Infections (7 papers). Andreas Fløe is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (16 papers) and Pneumonia and Respiratory Infections (7 papers). Andreas Fløe collaborates with scholars based in Denmark, Netherlands and Sweden. Andreas Fløe's co-authors include Christian Wejse, Victor Næstholt Dahl, Ole Hilberg, Troels Lillebæk, Thomas Schön, Jakko van Ingen, Martin Mølhave, Anders Løkke, Rikke Ibsen and Hans Jürgen Hoffmann and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Thorax.

In The Last Decade

Andreas Fløe

30 papers receiving 318 citations

Hit Papers

Global trends of pulmonary infections with nontuberculous... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Fløe Denmark 9 208 168 73 57 57 38 325
C. Andréjak France 12 212 1.0× 179 1.1× 91 1.2× 31 0.5× 93 1.6× 26 357
A M Hunter United Kingdom 9 225 1.1× 214 1.3× 50 0.7× 142 2.5× 195 3.4× 16 522
Sidney Bombarda Brazil 11 131 0.6× 156 0.9× 35 0.5× 81 1.4× 110 1.9× 21 308
Gustavo Ferrer United States 9 53 0.3× 67 0.4× 7 0.1× 44 0.8× 119 2.1× 41 270
Anders Lannergård Sweden 10 221 1.1× 60 0.4× 9 0.1× 43 0.8× 23 0.4× 18 363
Martín Lasso Chile 8 149 0.7× 181 1.1× 12 0.2× 57 1.0× 16 0.3× 12 318
Ethel Zimberg Chehter Brazil 11 63 0.3× 52 0.3× 22 0.3× 180 3.2× 48 0.8× 41 316
Behzad Razavi United States 9 195 0.9× 185 1.1× 7 0.1× 72 1.3× 9 0.2× 15 359
Cláudia Mauro Mano Brazil 7 82 0.4× 65 0.4× 12 0.2× 49 0.9× 110 1.9× 13 324
Stephen Morgan United Kingdom 8 70 0.3× 42 0.3× 10 0.1× 26 0.5× 48 0.8× 14 382

Countries citing papers authored by Andreas Fløe

Since Specialization
Citations

This map shows the geographic impact of Andreas Fløe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Fløe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Fløe more than expected).

Fields of papers citing papers by Andreas Fløe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Fløe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Fløe. The network helps show where Andreas Fløe may publish in the future.

Co-authorship network of co-authors of Andreas Fløe

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Fløe. A scholar is included among the top collaborators of Andreas Fløe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Fløe. Andreas Fløe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dahl, Victor Næstholt, Andreas Fløe, Frauke Rudolf, et al.. (2025). Clinical characteristics and diagnostic practices in nontuberculous mycobacterial pulmonary disease: Insights from Denmark. Respiratory Medicine. 241. 108055–108055. 1 indexed citations
5.
Kraef, Christian, Troels Lillebæk, Pernille Ravn, et al.. (2025). Risk of tuberculosis disease among patients with inflammatory bowel disease and inflammatory rheumatic disease treated with biologics in Denmark: a nationwide cohort study. Clinical Microbiology and Infection. 31(10). 1697–1703. 1 indexed citations
6.
Dahl, Victor Næstholt, Anders Løkke, Inge K. Holden, et al.. (2025). Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease. The International Journal of Tuberculosis and Lung Disease. 29(2). 60–66. 1 indexed citations
7.
Dahl, Victor Næstholt, et al.. (2024). The role of whole genome sequencing in identifying occupational tuberculosis among healthcare workers: two case reports. International Journal of Infectious Diseases. 145. 107088–107088.
8.
Løkke, Anders, et al.. (2024). Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark. CHEST Journal. 166(2). 271–280. 7 indexed citations
9.
Eklöf, Josefin, Pradeesh Sivapalan, Zitta Barrella Harboe, et al.. (2024). Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study. International Journal of COPD. Volume 19. 2169–2179.
10.
Aliberti, Stefano, Francesco Blasi, Pierre‐Régis Burgel, et al.. (2024). Mycobacterium aviumcomplex pulmonary disease patients with limited treatment options. ERJ Open Research. 10(1). 610–2023. 2 indexed citations
11.
Pedersen, Søren, et al.. (2023). Lung abscess: Clinical characteristics of 222 Danish patients diagnosed from 2016 to 2021. Respiratory Medicine. 216. 107305–107305. 7 indexed citations
12.
Fløe, Andreas, et al.. (2023). Pulmonary Mycobacterium abscessus infection treated in combination with inhaled tigecycline. BMJ Case Reports. 16(12). e255383–e255383. 1 indexed citations
13.
Pedersen, Søren, Steffen Leth, Andreas Fløe, et al.. (2023). Twelve-month follow-up after hospitalization for SARS-COV-2: Physiology improves, symptoms remain. Infectious Diseases Now. 53(6). 104686–104686. 2 indexed citations
14.
Dahl, Victor Næstholt, Andreas Fløe, & Christian Wejse. (2023). Nontuberculous mycobacterial infections in a Danish region between 2011 and 2021: evaluation of trends in diagnostic codes. Infectious Diseases. 55(6). 439–443. 8 indexed citations
15.
Stærke, Nina Breinholt, Ulla Møller Weinreich, Ole Hilberg, et al.. (2022). A cohort study of the long-term outcome of latent tuberculosis infection among socially marginalized people in a low-incidence country. International Journal of Infectious Diseases. 124. S56–S62. 1 indexed citations
16.
Pedersen, Søren, Andreas Fløe, Steffen Leth, et al.. (2022). Fatigue Is a Major Symptom at COVID-19 Hospitalization Follow-Up. Journal of Clinical Medicine. 11(9). 2411–2411. 16 indexed citations
17.
Stærke, Nina Breinholt, et al.. (2020). High yield from repeated testing for tuberculosis among high-risk citizens in Denmark. International Journal of Infectious Diseases. 102. 352–356. 4 indexed citations
18.
Stærke, Nina Breinholt, Ole Hilberg, Christian Wejse, Hans Jürgen Hoffmann, & Andreas Fløe. (2016). Latent tuberculosis infection is prevalent among socially marginalised citizens in Aarhus, Denmark.. PubMed. 63(7). 8 indexed citations
19.
Wejse, Christian, et al.. (2016). Latent tuberculosis infection is prevalent among socially marginalised citizens in Aarhus, Denmark. 1 indexed citations
20.
Fløe, Andreas, Ole Hilberg, Christian Wejse, et al.. (2015). The economic burden of Tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses. International Journal of Infectious Diseases. 32. 183–190. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026